The groundbreaking rise of Viagra has long been a example of pharmaceutical success, however its legacy within the broader market now presents questions about future yields . Generic versions are diminishing patent protection , leading to anxieties that investing in companies closely tied to Viagra's previous position could be a dangerous decision